294 related articles for article (PubMed ID: 31923104)
1. 3-Bromopyruvate alleviates the development of monocrotaline-induced rat pulmonary arterial hypertension by decreasing aerobic glycolysis, inducing apoptosis, and suppressing inflammation.
Liu J; Wang W; Wang L; Qi XM; Sha YH; Yang T
Chin Med J (Engl); 2020 Jan; 133(1):49-60. PubMed ID: 31923104
[TBL] [Abstract][Full Text] [Related]
2. 3-Bromopyruvate Attenuates Experimental Pulmonary Hypertension via Inhibition of Glycolysis.
Zhang YL; Zhang R; Shen YF; Huang KY; He YY; Zhao JH; Jing ZC
Am J Hypertens; 2019 Mar; 32(4):426-432. PubMed ID: 30561502
[TBL] [Abstract][Full Text] [Related]
3. 3-Bromopyruvate reverses hypoxia-induced pulmonary arterial hypertension through inhibiting glycolysis: In vitro and in vivo studies.
Chen F; Wang H; Lai J; Cai S; Yuan L
Int J Cardiol; 2018 Sep; 266():236-241. PubMed ID: 29735421
[TBL] [Abstract][Full Text] [Related]
4. Perillyl alcohol suppresses monocrotaline-induced pulmonary arterial hypertension in rats via anti-remodeling, anti-oxidant, and anti-inflammatory effects.
Beik A; Najafipour H; Joukar S; Rajabi S; Iranpour M; Kordestani Z
Clin Exp Hypertens; 2021 Apr; 43(3):270-280. PubMed ID: 33322932
[No Abstract] [Full Text] [Related]
5. 3-Bromopyruvate ameliorates pulmonary arterial hypertension by improving mitochondrial metabolism.
Guo Y; Liu X; Zhang Y; Qiu H; Ouyang F; He Y
Life Sci; 2020 Sep; 256():118009. PubMed ID: 32603819
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a.
Li F; Wang D; Wang H; Chen L; Sun X; Wan Y
Respir Res; 2021 Aug; 22(1):239. PubMed ID: 34465322
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Siah2 ubiquitin ligase ameliorates monocrotaline-induced pulmonary arterial remodeling through inactivation of YAP.
Wang Q; Shi W; Zhang Q; Feng W; Wang J; Zhai C; Yan X; Li M
Life Sci; 2020 Feb; 242():117159. PubMed ID: 31837334
[TBL] [Abstract][Full Text] [Related]
8. Shikonin improves pulmonary vascular remodeling in monocrotaline‑induced pulmonary arterial hypertension via regulation of PKM2.
Li W; Chen W; Peng H; Xiao Z; Liu J; Zeng Y; Huang T; Song Q; Wang X; Xiao Y
Mol Med Rep; 2023 Mar; 27(3):. PubMed ID: 36734266
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel alleviates monocrotaline-induced pulmonary arterial hypertension via inhibition of FoxO1-mediated autophagy.
Feng W; Wang J; Yan X; Zhai C; Shi W; Wang Q; Zhang Q; Li M
Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):605-613. PubMed ID: 30683943
[TBL] [Abstract][Full Text] [Related]
10. Early Intervention of Tongxinluo () on Right Ventricular Function Assessed by Echocardiography in Rats with Pulmonary Arterial Hypertension Induced by Monocrotaline.
Gao L; Li SD; Zhang Y; Liu Y; Yang MH
Chin J Integr Med; 2020 Dec; 26(12):913-920. PubMed ID: 32418178
[TBL] [Abstract][Full Text] [Related]
11. Formononetin attenuates monocrotaline‑induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats.
Cai C; Xiang Y; Wu Y; Zhu N; Zhao H; Xu J; Lin W; Zeng C
Mol Med Rep; 2019 Dec; 20(6):4984-4992. PubMed ID: 31702810
[TBL] [Abstract][Full Text] [Related]
12. Effect of estrogen on right ventricular remodeling of monocrotaline-induced pulmonary arterial hypertension in rats and its mechanism.
Liu Z; Duan YL; Ge SL; Zhang CX; Gong WH; Xu JJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1742-1750. PubMed ID: 30840299
[TBL] [Abstract][Full Text] [Related]
13. MiR-135a inhibitor alleviates pulmonary arterial hypertension through β-Catenin/GSK-3β signaling pathway.
Yu RH; Wang LM; Hu XH
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9574-9581. PubMed ID: 31773709
[TBL] [Abstract][Full Text] [Related]
14. Effects of Beet Juice Supplementation on Monocrotaline-Induced Pulmonary Hypertension in Rats.
Tawa M; Yano Y; Yamanaka M; Sawano T; Iesaki K; Murata Y; Tanaka R; Nakagawa K; Ohkita M; Matsumura Y
Am J Hypertens; 2019 Jan; 32(2):216-222. PubMed ID: 30265283
[TBL] [Abstract][Full Text] [Related]
15. Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-Mediated FAK Phosphorylation.
Zhai C; Zhang N; Wang J; Cao M; Luan J; Liu H; Zhang Q; Zhu Y; Xue Y; Li S
Lung; 2022 Oct; 200(5):619-631. PubMed ID: 36107242
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of hexokinase1 in the right ventricle of monocrotaline induced pulmonary hypertension.
Zhang WH; Qiu MH; Wang XJ; Sun K; Zheng Y; Jing ZC
Respir Res; 2014 Oct; 15(1):119. PubMed ID: 25287584
[TBL] [Abstract][Full Text] [Related]
17. Alginate Oligosaccharide Alleviates Monocrotaline-Induced Pulmonary Hypertension via Anti-Oxidant and Anti-Inflammation Pathways in Rats.
Feng W; Hu Y; An N; Feng Z; Liu J; Mou J; Hu T; Guan H; Zhang D; Mao Y
Int Heart J; 2020 Jan; 61(1):160-168. PubMed ID: 31956132
[TBL] [Abstract][Full Text] [Related]
18. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y
Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation.
Shi W; Zhai C; Feng W; Wang J; Zhu Y; Li S; Wang Q; Zhang Q; Yan X; Chai L; Liu P; Chen Y; Li M
Life Sci; 2018 Oct; 210():140-149. PubMed ID: 30179628
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stromal Cell-derived Exosomes Attenuate Experimental Pulmonary Arterial Hypertension.
Ge L; Jiang W; Zhang S; Wang J; Xin Q; Sun C; Li K; Qi T; Luan Y
Curr Pharm Biotechnol; 2021; 22(12):1654-1662. PubMed ID: 33390109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]